Abstract: Most video captioning models are designed to process short video clips of few seconds and output text describing low-level visual concepts (e.g., objects, scenes, atomic actions). However, ...

A large alligator was filmed dragging a massive Burmese python in Florida's Everglades National Park. The alligator was estimated to be 10 to 12 feet long, while the python appeared to be nearly twice ...

It was one Christmas visitor that didn’t overstay its welcome. A Burmese python that had been spotted in a Miami-Dade neighborhood was removed just days before Christmas after a resident out for a ...

'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power. Got a confidential news tip? We want to hear from you. Sign up ...

Recursion Pharmaceuticals doesn't have any products on the market. In fact, none of the company's candidates are currently in phase 3 studies. So, despite the biotech's claims that its AI-powered ...

Horrifying footage has captured the moment a six-meter python dragged a tour guide underwater, just moments before coiling around his neck. Experienced snake catcher, Heru, was traveling down a river ...

Miami-Dade firefighters discovered a Burmese python slithering through a shed outside a Miami-area home, and its capture was caught on video. Video released by the Miami-Dade Fire Rescue department ...

Reptile Hunter captures massive 16-foot python in downtown Los Angeles Reptile Hunter Joseph Hart tells 'Fox & Friends Weekend' about giving a second chance to a massive 16-foot python discovered in ...

RXRX stock looks like a deep-value growth bet at just $5 and change. Though the technology is exciting, I’m not rushing into shares just yet. The analyst who called NVIDIA in 2010 just named his top ...

A variation of a puzzle called the “pick-up sticks problem” asks the following question: If I have some number of sticks with random lengths between 0 and 1, what are the chances that no three of ...

Rallybio has swerved away from its Recursion Pharmaceuticals pact, accepting $7.5 million upfront for its share of a preclinical program to extend its cash runway to mid-2027. Exscientia, now part of ...